Bright Minds Biosciences Inc. (DRUG) vs Oculis Holding AG (OCS)
A side-by-side comparison of Bright Minds Biosciences Inc. and Oculis Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DRUG
Bright Minds Biosciences Inc.
$48.02HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
OCS
Oculis Holding AG
$8.66HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — DRUG vs OCS
growth of $100 · dividends reinvested · last 5yDRUG +104.6% (+15.4%/yr)OCS -11.8% (-2.5%/yr)DRUG compounded faster over this window
DRUG OCS
DRUG vs OCS: by the numbers
- •OCS is the larger company ($495M vs $470M market cap).
- •Both run net losses; DRUG's is the smaller (0.00% vs -32724.20% net margin).
Metrics side by side
Valuation
| Metric | DRUG | OCS |
|---|---|---|
| P/S ratio | N/A | 1622.78 |
| P/B ratio | 2.17 | 1.82 |
Profitability
| Metric | DRUG | OCS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -32724.20% |
| ROE | -8.21% | -36.79% |
| ROIC | -13.15% | -39.63% |
Growth (annualized)
| Metric | DRUG | OCS |
|---|---|---|
| Total return CAGR (5Y) | 6.76% | -2.41% |
Frequently asked
- How have DRUG and OCS total returns compared?
- Over the past 5 years, DRUG delivered 6.76% and OCS delivered -2.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.